April 2024

The scientist from P-CRM[C], IDIBELL and the University of Barcelona will lead a project aimed at identifying new early detection markers and developing personalized medicine strategies for this pathology.
The recognition granted by the CRIS Foundation against cancer aims to promote and consolidate the careers of researchers with an endowment of up to 1,250,000 euros.
In this call, grants totaling 11.4 million euros have been awarded to ensure that advances in research have a broader reach and impact the treatments received by patients.

Scientists led by Dr Anna Veiga and Dr Sergi Querol have generated seven pluripotent stem cell lines from umbilical cord blood, compatible with 20% of the Spanish population.

These induced pluripotent stem cells (iPSCs) are created from adult cells from umbilical cord blood and can be used to produce advanced therapy drugs and test them in clinical trials, for example in retinal regeneration, heart, or immunotherapies.

Certain variations in our DNA, which had previously gone unnoticed, can have a significant impact on the development of cancer.
62% of the cancer susceptibility genes identified are completely new, which opens up new avenues of study in cancer research.